Notes / Company

Brooks Laboratories Ltd.

BROOKS BSE 533543 ISIN INE650L01011 Pharmaceuticals

Fundamentals

Market cap: ₹196 cr
P/E: 7.99×
ROE: 0.00%
Debt / equity: 0.06
52-week range: 36.30 — 164.02

The timeline — 1 note on Brooks Laboratories Ltd.

June 2026

19 Jun 26 · 9:34 PM IST Alert

Alert · Micro cap

Brooks Labs nets ₹106 cr from stake sale, 53% of its market cap

Partial monetisation of Brooks Steriscience stake fetches ₹106 crore in cash, a huge inflow for the nano-cap drug maker that nearly doubles its cash position.

Verify on exchange BSE filings for BROOKS NSE filings for BROOKS